We recently had the opportunity and the pleasure to interview Dr. Ahmed Abdelaal, a consultant physician and one of the...
Home
Several indications and molecules were approved in December by FDA including the following: Abatacept for the prophylaxis of acute graft...
Post-hoc analyses of the Endari (L–glutamine) phase 3 clinical study in SCD presented at ASH showed a significant reduction of transfusion...
Several indications and molecules were approved in November by FDA including the following: 1- Pembrolizumab for the adjuvant treatment of...
Emirates Oncology Society (EOS) and Ipsen joined forces to raise awareness of Neuroendocrine Tumors (NET), a rare type of cancer....
Several indications and molecules were approved in October by FDA including the following: 1- Brexucabtagene autoleucel for adult patients with...
Brief Introduction: Spinal Muscular Atrophy is a neuromuscular illness that leads to advanced proximal muscle weakening and paralysis. It is...
Kite Pharma received FDA approval for brexucabtagene autoleuceladult to treat patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia...
Several indications and molecules were approved in August by FDA including the following: 1- Lenvatinib plus pembrolizumab for first-line treatment...
Several indications and molecules were approved in July by FDA including the following: Asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component...
